News – Page 1097 – Endpoints News

Tech maven Travis May takes the helm of Roivant's data mining startup

8 years ago

Alnylam achieves breakthrough RNAi success as PhIII patisiran study hits all goals, shares soar

8 years ago

From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world

8 years ago

Troubled Teva turns to risk-sharing team at Nuvelution to gamble on a new PhIII study

8 years ago

OptiNose files for $100M IPO; GSK wins three-in-one COPD OK

8 years ago

OncoMed chief Paul Hastings goes on medical leave

8 years ago

Highlighting a major shift at the FDA, regulators put Amicus' once-spurned drug on fast track

8 years ago

With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica and signals an appetite for ...

8 years ago

Atlas ramps up a new biotech player focused on neurology, with a $30M round to fund the work

8 years ago

Ex-GSK CEO, R&D chief Andrew Witty and Moncef Slaoui are jumping into the biotech VC game

8 years ago

AbbVie and Roche tout a positive PhIII combo study of Venclexta, Rituxan in CLL — ahead of FDA pitch

8 years ago

Avanir vet Keith Katkin takes charge at Urovant; Teva unloads assets while uploading new CEO

8 years ago

Harvard biotech wiz Greg Verdine grabs a $55M A round to build a groundbreaking biotech

8 years ago

Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal

8 years ago

Shares rocket up as Nabriva Therapeutics touts a PhIII win for antibiotic

8 years ago

Cut loose from Biogen buyout option, Rodin preps for an early-stage shot at Alzheimer’s

8 years ago

Sailing past the $2B mark, Flagship sets course for $500M-plus biotech fund, unveils a new startup

8 years ago

Closing in on another mega-raise, UK biotech star Immunocore grabs $40M investment from Gates Foundation

8 years ago

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths

8 years ago

Top 5 biopharma trends: The long-awaited biopharma revolution in China has arrived — don’t lose out

8 years ago

Lundbeck CEO bags $20M bonus jumping ship for Teva helm

8 years ago

Want to start a fight? Step one: Offer up an estimate for what it costs to develop a new drug

8 years ago

FDA takes a pass on pegvaliase panel; Flexion terminates an old AstraZeneca pact

8 years ago

Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients

8 years ago

First page Previous page 1094 1095 109610971098 1099 1100 Next page Last page